Recent Updates
Recently added Catalysts

lumbar corset

Phase 3

Lumbar Fusion | Unknown | Other |Medtronic plc.|Last Updated: Apr 20, 2020

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

PLACEBO_CONTROLLED
Total Trials1
Total Enrollment -

FDA Designations

No designations recorded

Clinical trial landscape

lumbar corset · 1 trial · 1 indication

Phase 3 1
NCT00620399A Study on the Use of a Brace Following Low Back SurgeryLumbar Fusion
COMPLETED- Analytics
PHASE3COMPLETED
A Study on the Use of a Brace Following Low Back Surgery
Lumbar FusionUnlock trial analytics

Study Endpoints

Primary Endpoints

functional outcome scores
2 years following surgery
Unlock Study Endpoints

Study Design & Arms

PurposeTREATMENT

Treatment Arms

ArmTypeDescription
1EXPERIMENTALbrace
2PLACEBO_COMPARATORno brace

Interventions

NameTypeDescription
lumbar corsetOTHER -
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to 80 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * Age 18-80 * Undergoing posterior lumbar fusion surgery for degenerative conditions Exclusion Criteria: * Unable to complete questionnaires due to language or cognitive barrier * Declined study participation

Countries:United States
Unlock Eligibility Criteria

Frequently asked questions about lumbar corset

What is lumbar corset used for?

The lumbar corset is a medical device used for lumbar fusion, a surgical procedure that joins two or more vertebrae in the lower back. It is intended to support the spine following low back surgery. The device is currently in Phase 3 clinical development and is being studied for this specific indication.

Who makes lumbar corset?

The lumbar corset is developed by Medtronic plc, a medical technology company. Medtronic is publicly traded under the ticker symbol MDT on the New York Stock Exchange. The company is conducting clinical research to evaluate the device's use in patients undergoing lumbar fusion surgery.

What phase is lumbar corset in?

The lumbar corset is in Phase 3 clinical development. It is an investigational device and has not yet been approved by regulatory authorities. The Phase 3 trial has been completed, and the device is being evaluated for its safety and effectiveness in supporting patients after low back surgery.

What clinical trials is lumbar corset in?

The lumbar corset has one completed clinical trial with the identifier NCT00620399, titled "A Study on the Use of a Brace Following Low Back Surgery." This Phase 3 trial was conducted in the United States and enrolled adult participants of all sexes. The study was placebo-controlled and evaluated the device's use in lumbar fusion patients.

Is lumbar corset FDA approved?

The lumbar corset is not FDA approved. It is an investigational device currently in Phase 3 clinical development. The completed clinical trial, NCT00620399, was a placebo-controlled study conducted in the United States. Regulatory approval has not been granted, and the device remains under investigation.

What does lumbar corset target?

The lumbar corset is a medical device, not a pharmaceutical, so it does not target a specific molecular pathway. Instead, it provides external support to the lumbar spine. It is designed to stabilize the lower back area following lumbar fusion surgery, potentially aiding in the healing process.